News | November 07, 2024
RPG Life Sciences posts Q2 FY25 revenue Up by 12% YoY
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
Shivani Satish Wagh takes on the role of Joint Managing Director
Subscribe To Our Newsletter & Stay Updated
